单细胞CRISPR查的特征是T细胞急性淋巴细胞白血病的转录失调
Sarah Meyers1, Olga Gielen1, Jan Cools2
1Center for Human Genetics, KU Leuven, Leuven, Belgium; Center for Cancer Biology, VIB, Leuven, Belgium; Leuvens Kanker Instituut (LKI), KU Leuven - UZ Leuven, Leuven.
Haematologica
|May 30, 2024
概括
这项研究使用单细胞CRISPR屏揭示了基因突变如何驱动T细胞急性淋巴细胞白血病 (T-ALL). 研究人员确定了Spi1和Bcl11b等关键基因,揭示了它们在T-ALL发育中的作用以及作为治疗点的潜力.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- T细胞急性淋巴细胞白血病 (T-ALL) 源于T细胞前代的遗传变化.
- 许多基因突变对T-ALL发展的确切贡献尚不清楚.
研究的目的:
- 研究T-ALL.中基因功能丧失突变的转录影响.
- 通过单细胞CRISPR屏幕,将这些变化与细胞健康的影响相关联.
主要方法:
- 在原发性T细胞中进行了两次单细胞CRISPR查.
- 基于对E2F/MYC和STAT/NOTCH信号通路的影响的集群干扰.
- 分析了基因表达,细胞健康和患者数据.
主要成果:
- 确定Spi1对亲T细胞存活至关重要,与MYC放松调节和表观遗传变化有关.
- Bcl11b被确定为T-ALL中的瘤抑制剂,与NF-kB和JAK/STAT信号相关.
- 发现了BCL11B水平与JAK/STAT突变之间的相关性,显示了BCL11b无活化和JAK3过活化之间的致癌合作.
结论:
- 单细胞CRISPR屏幕提供了对T-ALL转录放松调节的见解.
- 确定Spi1和Bcl11b作为T-ALL病变发生的关键基因.
- 揭示了T-ALL.中的潜在治疗标和瘤合作机制.
更多相关视频
07:37Performing an In Vitro Genome-Wide CRISPR Knockout Screen in Chimeric Antigen Receptor T Cells
Published on: January 31, 2025
819
07:01Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
Published on: May 2, 2025
116
相关概念视频
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR and crRNAs
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
The Antiviral System of Bacteria and Archaea: CRISPR
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this defense.
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
